Cresset Asset Management, LLC Novartis Ag Transaction History

Cresset Asset Management, LLC

$25.6 Billion
Q3 2024

A detailed history of Cresset Asset Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Cresset Asset Management, LLC holds 78,138 shares of NVS stock, worth $7.59 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

78,138

Previous 69,686 12.13%

Holding current value

$7.59 Million

Previous $7.42 Million 21.15%

% of portfolio

0.04%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$106.13 - $120.89 $897,010 - $1.02 Million	8,452 Added 12.13%	78,138 $8.99 Million
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $870,805 - $1.01 Million	9,407 Added 15.61%	69,686 $7.42 Million
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $252,179 - $287,120	2,647 Added 4.59%	60,279 $5.83 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $172,544 - $189,879	1,870 Added 3.35%	57,632 $5.82 Million
Q3 2023 Nov 14, 2023	BUY	$94.73 - $105.13 $254,539 - $282,484	2,687 Added 5.06%	55,762 $5.68 Million
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $3.04 Million - $3.44 Million	32,816 Added 161.98%	53,075 $5.36 Million
Q1 2023 May 12, 2023	BUY	$80.03 - $92.81 $13,365 - $15,499	167 Added 0.83%	20,259 $1.86 Million
Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $260,496 - $319,008	-3,448 Reduced 14.65%	20,092 $1.82 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $8,878 - $10,383	-119 Reduced 0.5%	23,540 $1.79 Million
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $81,405 - $94,781	-1,011 Reduced 4.1%	23,659 $2 Million
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $57,038 - $64,521	712 Added 2.97%	24,670 $2.17 Million
Q4 2021 Feb 10, 2022	SELL	$79.7 - $88.13 $159,718 - $176,612	-2,004 Reduced 7.72%	23,958 $2.1 Million
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $447,990 - $521,176	5,478 Added 26.74%	25,962 $2.12 Million
Q2 2021 Aug 10, 2021	SELL	$85.24 - $94.15 $624,042 - $689,272	-7,321 Reduced 26.33%	20,484 $1.87 Million
Q1 2021 May 12, 2021	BUY	$83.5 - $98.47 $179,107 - $211,218	2,145 Added 8.36%	27,805 $2.38 Million
Q4 2020 Feb 11, 2021	BUY	$78.07 - $94.43 $320,633 - $387,824	4,107 Added 19.06%	25,660 $2.42 Million
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $332,913 - $368,823	-4,053 Reduced 15.83%	21,553 $1.87 Million
Q2 2020 Aug 04, 2020	BUY	$80.93 - $91.1 $1.41 Million - $1.59 Million	17,432 Added 213.26%	25,606 $2.24 Million
Q1 2020 May 15, 2020	BUY	$70.67 - $99.01 $42,472 - $59,505	601 Added 7.94%	8,174 $674,000
Q4 2019 Feb 10, 2020	SELL	$84.35 - $95.37 $9,109 - $10,299	-108 Reduced 1.41%	7,573 $717,000
Q3 2019 Nov 13, 2019	BUY	$85.54 - $94.26 $256,534 - $282,685	2,999 Added 64.05%	7,681 $667,000
Q2 2019 Aug 12, 2019	SELL	$75.4 - $92.8 $69,745 - $85,840	-925 Reduced 16.5%	4,682 $428,000
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $180,993 - $207,018	2,403 Added 75.0%	5,607 $539,000
Q4 2018 May 21, 2019	BUY	$73.66 - $82.02 $236,006 - $262,792	3,204 New	3,204 $275,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.

Account

Cresset Asset Management, LLC Novartis Ag Transaction History